• Enhertu Approved in UK for Inoperable, Advanced Breast Cancer
  • Phase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC
  • Tukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer
  • Trial Testing AL101 in TNBC Doses First Patient
  • ‘Overwhelmingly Positive’ Data Halts Endoxifen Phase 2 Trial for Invasive Cancer
  • Theralink Begins Testing New Biomarker Assay for Breast Cancer Tumors
  • US Study Enrolling Women to Help Determine Best Screening Practices
  • Nonprofit Highlights Importance of Global Teamwork for World Cancer Day
  • Enhertu Approved in EU for Inoperable, Advanced Breast Cancer
  • Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA
  • Mindfulness Can Alter Brain’s Perception of Pain in Cancer Survivors
  • Genetic Test for Advanced Breast Cancer Launched in EU